Trinity Biotech agrees in principle to take minority stake in Latch Medical

Reuters2026/07/22 11:31

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Trinity Biotech agreed in principle to make a strategic equity investment in Latch Medical as part of a new collaboration.
Deal positions Trinity Biotech as a minority shareholder in Latch Medical alongside the partnership.
Investment aims to support development of biosensor-guided precision drug delivery using Trinity Biotech’s CGM+ platform with Latch Medical’s Pharma Latch technology.
Perceptive Advisors, Trinity Biotech’s largest financial investor, will support the planned equity investment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Trinity Biotech plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607220730PRIMZONEFULLFEED9766271) on July 22, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Trinity Biotech agrees in principle to take minority stake in Latch Medical

You may also like

Crypto prices